首页> 外文OA文献 >Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes

【2h】

Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes

机译：非细胞毒性苏拉司匹林的相I / II试验与先前紫杉烷治疗的转移性乳腺癌中的每周紫杉醇组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Maryam B. Lustberg; Shubham Pant; Amy S. Ruppert; Tong Shen; Yong Wei; Ling Chen; Lisa Brenner; Donna Shiels; Rhonda R. Jensen; Michael Berger; Ewa Mrozek; Bhuvaneswari Ramaswamy; Michael Grever; Jessie L. Au; M. Guillaume Wientjes; Charles L. Shapiro;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes [J] . LustbergM.B., PantS., RuppertA.S., Cancer chemotherapy and pharmacology. . 2012,第1期

机译：无细胞毒性苏拉明联合每周紫杉醇治疗先前紫杉烷类药物治疗转移性乳腺癌的I / II期试验
3. Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes [J] . Maryam B. Lustberg, Shubham Pant, Amy S. Ruppert, Cancer Chemotherapy and Pharmacology . 2012,第1期

机译：I / II期非细胞毒性苏拉明联合每周紫杉醇治疗先前紫杉烷类药物治疗转移性乳腺癌的临床研究
4. 5021 Everolimus (RAD001) in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab: a multicenter phase I clinical trial [J] . S.Hurvitz, R.ORegan, M.Campone, European Journal of Cancer Supplements . 2009,第2期

机译：5021依维莫司（RAD001）与每周紫杉醇和曲妥珠单抗联合治疗对先前对曲妥珠单抗有耐药性的HER-2过表达转移性乳腺癌（MBC）的患者（pts）：一项多中心I期临床试验
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. Enhancement of Gemcitabine and Paclitaxel Uptake and Retention in Metastatic Cancer Cells: A Novel Targeted Combination Delivery Approach to Eliminate Breast Cancer in Blood and Lymph [D] . Yu, Jesse. 2020

机译：吉西他滨和紫杉醇吸收的增强和转移性癌细胞的保留：一种小型靶向组合递送方法，消除血液和淋巴中的乳腺癌
7. Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes [O] . Maryam B. Lustberg, Shubham Pant, Amy S. Ruppert, -1

机译：非细胞毒性苏拉司匹林的相I / II试验与先前紫杉烷治疗的转移性乳腺癌中的每周紫杉醇组合
8. Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531) [O] . Roy, V., LaPlant, B. R., Gross, G. G., 2008

机译：转移性乳腺癌患者每周一次纳布（纳米颗粒结合白蛋白）-紫杉醇（纳布-紫杉醇）（Abraxane®）联合吉西他滨的II期临床试验（N0531）

Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes

著录项

引文网络

相似文献

相关主题

期刊订阅